Functional Recovery in Major Depressive Disorder: Providing Early Optimal Treatment for the Individual Patient
Open accessThe DOI matches its Crossref record; 166 of the 167 references it cites were found in a registry or an index.
Abstract
Major depressive disorder is an often chronic and recurring illness. Left untreated, major depressive disorder may result in progressive alterations in brain morphometry and circuit function. Recent findings, however, suggest that pharmacotherapy may halt and possibly reverse those effects. These findings, together with evidence that a delay in treatment is associated with poorer clinical outcomes, underscore the urgency of rapidly treating depression to full recovery. Early optimized treatment, using measurement-based care and customizing treatment to the individual patient, may afford the best possible outcomes for each patient. The aim of this article is to present recommendations for using a patient-centered approach to rapidly provide optimal pharmacological treatment to patients with major depressive disorder. Offering major depressive disorder treatment determined by individual patient characteristics (e.g., predominant symptoms, medical history, comorbidities), patient preferences and expectations, and, critically, their own definition of wellness provides the best opportunity for full functional recovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This dysfunction contributes to compulsive actions by reinforcing rigid, maladaptive response patterns that resist modification, thereby reducing cognitive flexibility, particularly in contexts involving task shifts, feedback adaptation, or updating based on new information (13, 21, 172).”
From Neural mechanisms underlying cognitive inflexibility in obsessive-compulsive disorder: a review (2026) · cites this paper as [172]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · cited 1×
“In addition to mood symptoms, individuals with MDD experience impairments in physical, occupational, and social functioning (Kessler et al., 2003; American Psychiatric Association, 2013).”
BackgroundOsterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
The PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898 · cited 11×
“Guideline-based validated instruments such as the PHQ-9 or Quick Inventory of Depressive Symptomatology, in contrast, are fast, easy, and self-administered (Kroenke and Spitzer, 2002; Rush et al., 2006a; Thase, 2014b).”
BackgroundMethodInfluentialRush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
KESSLER, R. C., ADLER, L., AMES, M., DEMLER, O., FARAONE, S., HIRIPI, E., HOWES, M. J., JIN, R., SECNIK, K., SPENCER, T., et al. (2005) · Psychological Medicine · doi:10.1017/s0033291704002892 · Cited by 3,452 · cited 2×
“, 2012), the authors recommend assessing for ADHD using the Adult ADHD Self-Report Scale (Kessler et al., 2005) in patients with treatment-resistant depression.”
MethodAssessment of social adjustment by patient self report.
Weissman, M. M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090101010 · Cited by 1,782 · cited 1×
“…7 scored on a 5-point, Likert scale Lam et al., 2009) Social Adjustment Scale, Self-Report Version 48 items in 6 domains, each rated on a 5-point, Likert scale Weissman and Bothwell, 1976 Social and Occupational Functioning Assessment Scale Single scale, scored 0–100 Rybarczyk, 2011 EuroQoL-5D…”
Method
Research works printed but not linked: 5
- American Psychiatric Association, 2013, Major depressive disorder, 160
- Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA), 2011, Canadian ADHD Practice Guidelines
- Canadian Network for Mood and AnxietyTreatments, 2017, SwitchRx: switching antipsychotic medications
- Sheehan, 2000, Sheehan Disability Scale, 113
- Work Group on Major Depressive Disorder. Practice Guideline For the Treatment of Patients With Major Depressive Disorder, edition 3. American Psychiatric Association, 2010
Cited by
Items 101–103 of 103
Feng, H., Chien, L., Lin, C., Liang, C.-Y., & Tzeng, W. (2026) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_159_25
Hopwood, M., Codyre, D., Barton, D., Scott, E. M., Puig, A., King, J., & Hickie, I. B. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.07.011
Neuroplasticity-Based Treatment Prioritization in Major Depressive Disorder: A Two-Cohort StudyPreprint
Solal, T. C., Amiaz, R., Maman, M., Kassner, Z., Keller, G., Ami, D. B., Jaremko, M., Aloni, E., Goldman, O., Fava, M., et al. (2026) · medRxiv · doi:10.64898/2026.10.06.26364759
Metadata
- Authors
- Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P.
- Affiliations
- University of Calgary (CA)
- START Clinic (CA)
- University of Toronto (CA)
- University of British Columbia (CA)
- Queen's University (CA)
- University of Ottawa (CA)
- Corresponding author
- Oluboka, Oloruntoba J
- ORCID
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-08
- Volume
- 21
- Issue
- 2
- Pages
- 128-144
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC5793729
- OpenAlex
- W2753506619
- Cited by
- 104
- References
- 167
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 3 · 2023: 8 · 2022: 27 · 2021: 14 · 2020: 11 · 2019: 12 · 2018: 5
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Pfizer Canada
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- major depressive disorder, functional recovery, early treatment, pharmacotherapy, measurement-based care, personalized treatment, patient-centered care, treatment delay, brain morphometry, comorbidities, patient preferences
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Patient-Centered Care, Patient Preference, Early Medical Intervention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
